Document is current
Any future updates will be listed below
-
Authors
Varmazyad, Mahboubeh
Gavlock, Dillon C.
Castiglione, Michael W.
DeBiasio, Richard
LaRocca, Gregory
Reese, Celeste
Vernetti, Lawrence A.
Schurdak, Mark
Stern, Andrew M.
Taylor, D. Lansing
Miedel, Mark T.
Brown, Jacquelyn A.
-
Funding
Funding for this research was provided by:
National Institutes of Health (1U2C TR004863)
National Institutes of Health, United States (4UH3TR003289)
- License Information
-
More Information
Article History
Received: 8 July 2025
Accepted: 8 January 2026
First Online: 9 February 2026
Declarations
:
: were not required for this study, as only commercially available cell lines and fully de-identified primary cells were used. According to U.S. federal regulations (45 CFR 46, the Common Rule), such materials do not constitute human subjects research and therefore fall outside the scope of IRB review requirements.
: Not applicable.
: Not applicable.
: The authors declare no competing interests.
